Literature DB >> 27728982

Desmoplastic melanoma: a challenge for the oncologist.

Marco Manfredini1, Giovanni Pellacani1, Lorena Losi2, Monia Maccaferri3, Aldo Tomasi3, Giovanni Ponti3.   

Abstract

AIM: To evaluate clinical, pathologic and genetic features of desmoplastic melanoma (DM). MATERIALS &
METHODS: Analysis of all DM records from 1991 to 2015.
RESULTS: The most common location of DMs was the head and neck (69%); median age and follow-up were 60.5 and 7.3 years, respectively. A familial predisposition for DMs and others malignancies was analyzed. Thin Breslow thickness (<4.5 mm) was associated with an intraepidermal component or a previous lentigo maligna, whereas high Breslow thickness (>4.5 mm) was observed in 'pure' DM.
CONCLUSION: DM could progress from an early phase, characterized by an intraepidermal component, to late phase, characterized by a dermal nodule. This hypothesis correlates with melanoma genetic and NF1 mutation, which could be an early event in the progression of DM.

Entities:  

Keywords:  NF1; desmoplastic melanoma; lentigo maligna melanoma; mixed desmoplastic melanoma; pure desmoplastic melanoma; spindle cell melanoma; stromal collagenization

Mesh:

Year:  2016        PMID: 27728982     DOI: 10.2217/fon-2016-0334

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

1.  Desmoplastic melanoma versus spindle cell melanoma: Incidence and survival, 1973 to 2017.

Authors:  Zhe Xu; Feiluore Yibulayin; Ping Shi; Lei Feng
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

2.  Desmoplastic melanoma: Demographic and clinicopathological features and disease-specific prognostic factors.

Authors:  Ping Shi; Zhe Xu; Xin Lei; Feiluore Yibulayin; Alimujiang Wushou
Journal:  Oncol Lett       Date:  2019-04-17       Impact factor: 2.967

3.  Desmoplastic Melanoma: Clinical Characteristics and Survival in the US Population.

Authors:  Maria T Huayllani; Andrea Sisti; David J Restrepo; Daniel Boczar; Jordan J Cochuyt; Aaron C Spaulding; Sanjay P Bagaria; Brian D Rinker; Antonio J Forte
Journal:  Cureus       Date:  2019-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.